Brief: Obseva Enters Into Licensing Agreement With Theramex
10/02/2022 21:13
Feb 10 (Reuters) - Obseva SA OBSN.S :
* OBSEVA ENTERS INTO LICENSING AGREEMENT WITH THERAMEX FOR
THE
COMMERCIALIZATION OF LINZAGOLIX
* OBSEVA SA - ENTITLED TO RECEIVE ROYALTIES OF A
MID-THIRTIES
PERCENTAGE ON COMMERCIAL SALES, WHICH INCLUDES COST OF GOODS
SOLD TO THERAMEX
* OBSEVA SA - AGREEMENT CONTAINS UP TO EUR72.75 MILLION IN
UPFRONT
AND MILESTONE PAYMENTS
Source text for Eikon: ID:nGNXSGdBn
Further company coverage: OBSN.S
((reuters.briefs@thomsonreuters.com;))
Recent news on Obseva SA
See all newsBrief: Obseva Announces Wind-Down Of Operations And Likely Not Going To Be Able To Satisfy Requirements For Maintaining Its Listing
Brief: Obseva Applies For Moratorium To Facilitate Pivotal Deals
Brief: Obseva SA Says Xoma Will Receive Full Worldwide Rights On Ebopiprant Following Termination Of License Agreement With Organon
Brief: Obseva Appoints Fabien De Ladonchamps As Chief Executive Officer Effective May 1, 2023
Brief: Obseva Announces Change Of Central Securities Depositary